NTRA Natera, Inc. $23.23B $169.27 BIIB Biogen Inc. $21.49B $146.57 INCY Incyte Corporation $16.36B $83.80 TEM Tempus AI, Inc. $16.26B $96.39 ILMN Illumina, Inc. $14.43B $93.86 MRNA Moderna, Inc. $10.44B $26.83 GH Guardant Health, Inc. $8.01B $64.22 NTLA Intellia Therapeutics, Inc. $2.63B $24.52 GRAL GRAIL, Inc. $2.38B $66.13 ADPT Adaptive Biotechnologies Corporation $2.31B $15.17 TWST Twist Bioscience Corporation $1.88B $31.19 TXG 10x Genomics, Inc. $1.43B $11.47 MAZE Maze Therapeutics, Inc. $1.20B $27.43 RLAY Relay Therapeutics, Inc. $1.12B $6.50 PGEN Precigen, Inc. $927.51M $3.12 DNA Ginkgo Bioworks Holdings, Inc. $749.39M $13.52 PSNL Personalis, Inc. $720.06M $8.12 MYGN Myriad Genetics, Inc. $697.83M $7.50 FLGT Fulgent Genetics, Inc. $689.01M $22.51 ARCT Arcturus Therapeutics Holdings Inc. $514.58M $18.95 PACB Pacific Biosciences of California, Inc. $426.53M $1.42 DSGN Design Therapeutics, Inc. $384.40M $6.75 NEO NeoGenomics, Inc. $231.81M $9.10 FHTX Foghorn Therapeutics Inc. $229.51M $4.06 PEPG PepGen Inc. $154.65M $4.71 MGX Metagenomi, Inc. Common Stock $107.34M $2.86 CAMP CAMP4 Therapeutics Corporation $74.80M $3.71 BNGO Bionano Genomics, Inc. $6.56M $1.95